CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 132 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $654 | -16.0% | 23,780 | +3.6% | 0.00% | 0.0% |
| Q2 2023 | $779 | -21.4% | 22,959 | -16.6% | 0.00% | 0.0% |
| Q1 2023 | $991 | -32.0% | 27,545 | -15.7% | 0.00% | -50.0% |
| Q4 2022 | $1,457 | -99.8% | 32,679 | -0.1% | 0.00% | +100.0% |
| Q3 2022 | $920,000 | +4.7% | 32,719 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $879,000 | -21.1% | 32,622 | -0.3% | 0.00% | 0.0% |
| Q1 2022 | $1,114,000 | -11.8% | 32,705 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $1,263,000 | -23.4% | 32,681 | +7.1% | 0.00% | -50.0% |
| Q3 2021 | $1,648,000 | +46.6% | 30,516 | -9.2% | 0.00% | +100.0% |
| Q2 2021 | $1,124,000 | – | 33,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|